CORP BRIEF: Key Alliance, Censof Holdings, Yong Tai, Metronoic Global

Key Alliance buys shares in Komarkcorp

KEY Alliance Group Bhd (KAG) has acquired 7.15 million ordinary shares representing 2.68% of the total issued and paid-up share capital of Komarkcorp Bhd for RM6.96 million. In a filing to the stock exchange yesterday, KAG, an information communications technology solutions provider, said the group sought to segue into healthcare applications, appliances and trading, and has begun to supply Komarkcorp masks on a regular basis. With its recent key partnerships within the medical distribution fraternity, and with Komarkcorp producing surgical grade face masks, KAG is facilitating the supply chain by bundling, bulk-breaking and supplying surgical masks for local and export footprints. — Bernama

Censof secures RM10.1m contract from MoF

CENSOF Holdings Bhd’s wholly-owned subsidiary, Century Software (M) Sdn Bhd, has accepted a contract from the Ministry of Finance (MoF) to provide maintenance and support services for the ministry’s budget management information system, MyResults. In a filing to Bursa Malaysia yesterday, Censof said the tenure of the RM10.12 million contract is two years, commencing from Jan 1, 2021 to Dec 31, 2022. The board is of the opinion that the contract will contribute positively to the earnings per share and the future earnings of Censof Group. — Bernama

Yong Tai to distribute Covid-19 vaccine

YONG Tai Bhd is finalising plans to distribute Covid-19 vaccine through its latest partnerships with Tiong Nam Logistics Solutions Sdn Bhd and Healthcliqs Sdn Bhd. In a statement yesterday, Yong Tai said it has engaged Tiong Nam to provide logistics services which include transportation, warehouse space and distribution of pharmaceutical products. The group is collaborating with Healthcliqs, a digital healthcare solutions provider, to facilitate the view and order for all pharmaceutical products under their system. — Bernama

Metronic unit’s MoA with Medigen terminated

METRONIC Global Bhd’s subsidiary, Metronic Medicare Sdn Bhd, and Taiwan-based Medigen Vaccine Biologics Corp (MVC) have mutually agreed to terminate their memorandum of agreement (MoA) on the exclusive distribution rights for MVC’s Covid-19 vaccine. In a filing to Bursa Malaysia yesterday, Metronic Global said the MoA was terminated as the company had not paid the deposit totalling US$1.5 million (RM6.01 million) to MVC within the agreed time frame. On Nov 20 last year, Metronic said under the terms of the MoA, the parties agreed that Metronic Medicare shall deposit US$1.5 million with MVC within one month after the signing of the MoA, and apply the refundable deposit to the purchase price of orders for the finished product. — Bernama


Thursday, November 23, 2017

Progenet to be 1st E2E cloud provider

Wednesday, July 29, 2020

Key Alliance raises stake in XOX